The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Provectus Biopharmaceuticals, Inc. - Specializes in Developing Oncology and Dermatology Treatments

SNNLive spoke with Peter R. Culpepper, CFO and COO of Provectus Biopharmaceuticals, Inc. (NYSE Mkt: PVCT) at the Growth Capital Expo 2015 in Las Vegas, NV.

Share With

Tuesday, July 28, 2015

   

© 2017 Stock News Now